Oncologic Results of Retroperitoneoscopic Versus Open Surgery for T2 Upper Tract Urothelial Carcinoma
Hongli Shan,Xiaoqing Wang,Qingnian Sun,Qihui Chen,Bo Xu,Yuanyuan Hao,Wei Xu
DOI: https://doi.org/10.1016/j.clgc.2015.05.011
IF: 3.121
2015-01-01
Clinical Genitourinary Cancer
Abstract:The oncologic results of laparoscopic nephroureterectomy for pathological tumor stage T2 (pT2) upper tract urothelial carcinoma (UTUC) remain controversial. This study was designed to compare oncologic outcomes of T2 UTUC patients treated with retroperitoneoscopic nephroureterectomy (RNU) or open radical nephroureterectomy. The results showed that RNU represents a safe, minimally invasive procedure, and it produces equally beneficial oncologic results as the traditional, and more risky, open surgery procedure. Background: The present study was designed to compare oncologic outcomes of T2 upper tract urothelial carcinoma patients treated with retroperitoneoscopic nephroureterectomy (RNU) or open radical nephroureterectomy (ONU). Patients and Methods: T2 upper tract urothelial carcinoma patients were treated with RNU (n = 110) or ONU (n = 118) and followed-up for > 5 years. Demographic and clinical data, including preoperative indexes, intraoperative indexes, and oncological outcomes, were retrospectively compared to determine the efficacy of the 2 procedures. Results: The RNU and ONU groups were statistically similar in age, sex, tumor location, and tumor pathologic grade. The original surgery time required for RNU and ONU was statistically similar, but RNU was associated with a significantly smaller volume of intraoperative estimated blood loss and shorter length of postoperative hospital stay. Follow-up (average: 43.2 months; range, 6-72 months) revealed that the estimated 5-year overall survival rate and the estimated 5-year disease-specific survival rate after RNU was slightly worse than after ONU (66.0% vs. 67.1%, and 80.8% vs. 83.8%, respectively), and the estimated 5-year recurrence-free survival rate and the estimated 5-year intravesical recurrence-free survival rates were slightly better than ONU (79.5% vs. 77.9%, and 68.3% vs. 65.6%, respectively). However, none of these differences were statistically significant. Conclusion: The open surgery strategy and the RNU strategy are equally effective for treating T2 upper tract urothelial carcinoma. However, the RNU procedure is safer, less invasive, and requires a shorter duration of postoperative hospitalized, care; thus, RNU is recommended as the preferred strategy. (C) 2015 Elsevier Inc. All rights reserved.